122 related articles for article (PubMed ID: 2428943)
21. Huntington's disease is accompanied by changes in the distribution of somatostatin-containing neuronal processes.
Marshall PE; Landis DM
Brain Res; 1985 Mar; 329(1-2):71-82. PubMed ID: 2858256
[TBL] [Abstract][Full Text] [Related]
22. Interrelationship of the distribution of neuropeptides and tyrosine hydroxylase immunoreactivity in the human substantia Nigra.
Haber SN; Groenewegen HJ
J Comp Neurol; 1989 Dec; 290(1):53-68. PubMed ID: 2480370
[TBL] [Abstract][Full Text] [Related]
23. Comparative distribution of neurokinin B-, substance P- and enkephalin-like immunoreactivities and neurokinin B messenger RNA in the basal forebrain of the rat: evidence for neurochemical compartmentation.
Marksteiner J; Saria A; Krause JE
Neuroscience; 1992 Nov; 51(1):107-20. PubMed ID: 1281522
[TBL] [Abstract][Full Text] [Related]
24. Cannabinoid (CB(1)), GABA(A) and GABA(B) receptor subunit changes in the globus pallidus in Huntington's disease.
Allen KL; Waldvogel HJ; Glass M; Faull RL
J Chem Neuroanat; 2009 Jul; 37(4):266-81. PubMed ID: 19481011
[TBL] [Abstract][Full Text] [Related]
25. Deep brain stimulation for Gilles de la Tourette syndrome: a case series targeting subregions of the globus pallidus internus.
Martínez-Fernández R; Zrinzo L; Aviles-Olmos I; Hariz M; Martinez-Torres I; Joyce E; Jahanshahi M; Limousin P; Foltynie T
Mov Disord; 2011 Aug; 26(10):1922-30. PubMed ID: 21538528
[TBL] [Abstract][Full Text] [Related]
26. Time-dependent changes in iron levels and associated neuronal loss within the substantia nigra following lesions within the neostriatum/globus pallidus complex.
Sastry S; Arendash GW
Neuroscience; 1995 Aug; 67(3):649-66. PubMed ID: 7545796
[TBL] [Abstract][Full Text] [Related]
27. Distribution of substance P and enkephalin-like immunoreactivity in the substantia nigra of rat, cat and monkey.
Inagaki S; Parent A
Brain Res Bull; 1984 Aug; 13(2):319-29. PubMed ID: 6208980
[TBL] [Abstract][Full Text] [Related]
28. The ventral striatopallidal parts of the basal ganglia in the rat--II. Compartmentation of ventral pallidal efferents.
Zahm DS
Neuroscience; 1989; 30(1):33-50. PubMed ID: 2473414
[TBL] [Abstract][Full Text] [Related]
29. Efferent connections of the ventral pallidum: evidence of a dual striato pallidofugal pathway.
Haber SN; Groenewegen HJ; Grove EA; Nauta WJ
J Comp Neurol; 1985 May; 235(3):322-35. PubMed ID: 3998213
[TBL] [Abstract][Full Text] [Related]
30. Enkephalin, dynorphin and substance P in postmortem substantia nigra from normals and schizophrenic patients.
Iadarola MJ; Ofri D; Kleinman JE
Life Sci; 1991; 48(20):1919-30. PubMed ID: 1708847
[TBL] [Abstract][Full Text] [Related]
31. Regulation of dopamine receptor and neuropeptide expression in the basal ganglia of monkeys treated with MPTP.
Betarbet R; Greenamyre JT
Exp Neurol; 2004 Oct; 189(2):393-403. PubMed ID: 15380489
[TBL] [Abstract][Full Text] [Related]
32. Cellular and subcellular localization of 5-hydroxytryptamine1B receptors in the rat central nervous system: immunocytochemical, autoradiographic and lesion studies.
Sari Y; Miquel MC; Brisorgueil MJ; Ruiz G; Doucet E; Hamon M; Vergé D
Neuroscience; 1999; 88(3):899-915. PubMed ID: 10363826
[TBL] [Abstract][Full Text] [Related]
33. Peptides derived from prodynorphin are decreased in basal ganglia of Huntington's disease brains.
Dawbarn D; Zamir N; Waters CM; Hunt SP; Emson PC; Brownstein MJ
Brain Res; 1986 Apr; 372(1):155-8. PubMed ID: 2871898
[TBL] [Abstract][Full Text] [Related]
34. Regional distribution of methionine-enkephalin and substance P-like immunoreactivity in normal human brain and in Huntington's disease.
Emson PC; Arregui A; Clement-Jones V; Sandberg BE; Rossor M
Brain Res; 1980 Oct; 199(1):147-60. PubMed ID: 6157454
[TBL] [Abstract][Full Text] [Related]
35. Direct projections from the central amygdaloid nucleus to the globus pallidus and substantia nigra in the cat.
Shinonaga Y; Takada M; Mizuno N
Neuroscience; 1992 Dec; 51(3):691-703. PubMed ID: 1283209
[TBL] [Abstract][Full Text] [Related]
36. [Control of inner speech and Gilles de la Tourette's syndrome].
Vercueil L
Encephale; 2003; 29(5):460-2. PubMed ID: 14615696
[TBL] [Abstract][Full Text] [Related]
37. Iron concentration reduced in ventral pallidum, globus pallidus, and substantia nigra by GABA-transaminase inhibitor, gamma-vinyl GABA.
Hill JM
Brain Res; 1985 Sep; 342(1):18-25. PubMed ID: 4041811
[TBL] [Abstract][Full Text] [Related]
38. Dopamine-opiate interaction in the regulation of neostriatal and pallidal neuronal activity as assessed by opioid precursor peptides and glutamate decarboxylase messenger RNA expression.
Mavridis M; Besson MJ
Neuroscience; 1999; 92(3):945-66. PubMed ID: 10426535
[TBL] [Abstract][Full Text] [Related]
39. [3H]SCH 23390 binding to D1 dopamine receptors in the basal ganglia of the cat and primate: delineation of striosomal compartments and pallidal and nigral subdivisions.
Besson MJ; Graybiel AM; Nastuk MA
Neuroscience; 1988 Jul; 26(1):101-19. PubMed ID: 2901690
[TBL] [Abstract][Full Text] [Related]
40. Topographic projections of substance P and GABA pathways in the striato- and pallido-nigral system: a biochemical and immunohistochemical study.
Jessell TM; Emson PC; Paxinos G; Cuello AC
Brain Res; 1978 Sep; 152(3):487-98. PubMed ID: 356929
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
